61 related articles for article (PubMed ID: 17667236)
1. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Acute Central Venous Catheters for Hemodialysis with Sodium Bicarbonate versus an Antibiotic Catheter Locking Solution.
Ali SS; Swami R; Shakir A; Mehta K
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):507-513. PubMed ID: 38725200
[TBL] [Abstract][Full Text] [Related]
3. Variables Leading to Usage of Alteplase Versus Heparin Lock in Patients With Tunneled Catheters in Hemodialysis Care Project Centers, Saudi Arabia.
Alhammouri J; Ockhuis D; Hibionada E; Albalawi M; Alnahdi R; Hikal B; Koko E; Alano MML; Troncoso M; Hashmi MN
Cureus; 2024 May; 16(5):e60817. PubMed ID: 38910780
[TBL] [Abstract][Full Text] [Related]
4. Convective Leakage Makes Heparin Locking of Central Venous Catheters Ineffective Within Seconds: Experimental Measurements in a Model Superior Vena Cava.
Barbour MC; McGah PM; Ng CH; Clark AM; Gow KW; Aliseda A
ASAIO J; 2015; 61(6):701-9. PubMed ID: 26418203
[TBL] [Abstract][Full Text] [Related]
5. Direct cost of maintenance of totally implanted central venous catheter patency.
Homo RFB; Lima AFC
Rev Lat Am Enfermagem; 2018 Jul; 26():e3004. PubMed ID: 30020336
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Dialysis Catheter Malfunction with Urokinase and Heparin: A Randomized, Controlled Trial.
Wang Q; Jiang N; Chen W; Cheng L; Fu S; Li Q; Li H
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38330567
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of the Impact of Antibiotic and Antimicrobial Catheter Locks on Catheter-Related Infections in Adult Patients Receiving Hemodialysis.
Haq A; Patel D; Gutlapalli SD; Hernandez GN; Seffah KD; Zaman MA; Awais N; Satnarine T; Ahmed A; Khan S
Cureus; 2023 Sep; 15(9):e45000. PubMed ID: 37829985
[TBL] [Abstract][Full Text] [Related]
8. Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients.
Oliveira FJG; Rodrigues AB; Ramos IC; Caetano JÁ
Rev Lat Am Enfermagem; 2020; 28():e3304. PubMed ID: 32578754
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Tetrasodium EDTA 4% with Sodium Citrate 4% as Line-Locking Solutions at 2 Tertiary Hemodialysis Centres.
Gage B; Shalansky K; Lau W; Harris C; Kiaii M
Can J Hosp Pharm; 2024; 77(1):e3447. PubMed ID: 38204515
[TBL] [Abstract][Full Text] [Related]
10. Spurious Hyperphosphatemia in Two Children With End-Stage Renal Disease: A Case Report.
Ahmed FS; Begum M; AlSharhan MA
Cureus; 2024 Mar; 16(3):e55818. PubMed ID: 38590456
[TBL] [Abstract][Full Text] [Related]
11. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
Wang Y; Sun X
Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
[TBL] [Abstract][Full Text] [Related]
13. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial.
El-Hennawy AS; Frolova E; Romney WA
Nephrol Dial Transplant; 2019 Oct; 34(10):1739-1745. PubMed ID: 30668833
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009631. PubMed ID: 27039404
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.
Ward DR; Moist LM; MacRae JM; Scott-Douglas N; Zhang J; Tonelli M; Lok CE; Soroka SD; Hemmelgarn BR
Can J Kidney Health Dis; 2014; 1():15. PubMed ID: 25960883
[TBL] [Abstract][Full Text] [Related]
16. Minimizing hemodialysis catheter dysfunction: an ounce of prevention.
Lee T; Lok C; Vazquez M; Moist L; Maya I; Mokrzycki M
Int J Nephrol; 2012; 2012():170857. PubMed ID: 22518310
[TBL] [Abstract][Full Text] [Related]
17. Does the heparin lock concentration affect hemodialysis catheter patency?
Ivan DM; Smith T; Allon M
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1458-62. PubMed ID: 20498241
[TBL] [Abstract][Full Text] [Related]
18. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
19. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
